RIVERCELL
Live / Allowed — Notice of allowance issued (as of 11 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 16 Jan 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99599095
- Mark type
- Word mark
- Filed
- 16 Jan 2026
- Published for opposition
- 16 Jun 2026
- Attorney of record
- Ryan Van Olst
Goods and services
- Class 009 — Scientific and electric apparatus: Downloadable and recorded software for predicting cellular behavior by collecting, analyzing, and organizing data, analyzing cell behavior and physiology, and modeling biological responses, and supporting drug discovery research and innovation by collecting, analyzing, and organizing data, generating insights about cell states and cell responses to perturbations, and evaluating drug candidates; downloadable and recorded computer software using artificial intelligence (AI) for predicting cellular behavior by collecting, analyzing, and organizing data, using machine learning on images and sequencing output, and modeling biological responses, and supporting drug discovery research and innovation by collecting, analyzing, and organizing data, generating insights about cell states and cell responses to perturbations, and evaluating drug candidates; downloadable and recorded software for generating data in the fields of cell biology, biotechnology, and drug discovery; downloadable and recorded computer software using artificial intelligence (AI) for generating data in the fields of cell biology, biotechnology, and drug discovery; laboratory equipment, namely, liquid handlers in the nature of laboratory robots, microscopes and incubators
- Class 042 — Scientific and technological services: Scientific research and development services in the fields of cell biology, biotechnology, and drug discovery; conducting scientific research in the fields of cell biology, biotechnology, and drug discovery; conducting cell perturbation experiments for scientific research and drug discovery purposes, namely, scientific research and drug discovery services; data generation, curation, and analysis in the nature of scientific research services in the fields of cell biology, biotechnology, and drug discovery; providing temporary use of non-downloadable cloud-based software for predicting cellular behavior by collecting, analyzing, and organizing data, analyzing cell behavior and physiology, and modeling biological responses, and supporting drug discovery research and innovation by collecting, analyzing, and organizing data, generating insights about cell states and cell responses to perturbations, and evaluating drug candidates; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for predicting cellular behavior by collecting, analyzing, and organizing data, using machine learning on images and sequencing output, and modeling biological responses, and supporting drug discovery research and innovation by collecting, analyzing, and organizing data, generating insights about cell states and cell responses to perturbations, and evaluating drug candidates; providing temporary use of non-downloadable cloud-based software for generating data in the fields of cell biology, biotechnology, and drug discovery; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for generating data in the fields of cell biology, biotechnology, and drug discovery
- Class 045 — Legal and security services: Licensing of intellectual property rights in the fields of cell biology, biotechnology, and drug discovery
Owner
- Blossom Life Sciences SAS, Paris, FR
- Blossom Life Sciences SAS, Paris, FR
Prosecution history
- 11 Aug 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Jun 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Jun 2026 — PUBLISHED FOR OPPOSITION
- 10 Jun 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 May 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 May 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 20 May 2026 — EXAMINER'S AMENDMENT ENTERED
- 20 May 2026 — EXAMINERS AMENDMENT E-MAILED
- 20 May 2026 — EXAMINERS AMENDMENT -WRITTEN
- 19 May 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 May 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 May 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 May 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 May 2026 — NON-FINAL ACTION E-MAILED
- 14 May 2026 — NON-FINAL ACTION WRITTEN